Roman Hakl

606 total citations
19 papers, 171 citations indexed

About

Roman Hakl is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Roman Hakl has authored 19 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 7 papers in Hematology and 5 papers in Immunology. Recurrent topics in Roman Hakl's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Mast cells and histamine (4 papers) and Vitamin K Research Studies (4 papers). Roman Hakl is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Mast cells and histamine (4 papers) and Vitamin K Research Studies (4 papers). Roman Hakl collaborates with scholars based in Czechia, United States and Slovakia. Roman Hakl's co-authors include Jiří Litzman, Tomáš Freiberger, Sladjana Andrejević, Pavlína Králíčková, Anurag Relan, Vesna Grivcheva‐Panovska, Irena Krčmová, Marcela Vlková, Dumitru Moldovan and James Baker and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Roman Hakl

17 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Hakl Czechia 8 130 64 49 41 39 19 171
Fotis Psarros Greece 9 159 1.2× 77 1.2× 50 1.0× 31 0.8× 54 1.4× 14 227
Marianna De Muro Italy 9 153 1.2× 12 0.2× 38 0.8× 162 4.0× 10 0.3× 16 229
Cecelia Perkins United States 4 49 0.4× 93 1.5× 74 1.5× 37 0.9× 13 0.3× 11 157
Elisabetta Colaci Italy 6 59 0.5× 30 0.5× 23 0.5× 64 1.6× 28 0.7× 11 112
Tülin Tuğlular Türkiye 7 87 0.7× 34 0.5× 37 0.8× 93 2.3× 9 0.2× 25 174
Juliana Schwaab Germany 6 60 0.5× 59 0.9× 37 0.8× 59 1.4× 10 0.3× 14 141
Giuseppe Auteri Italy 7 63 0.5× 22 0.3× 33 0.7× 87 2.1× 12 0.3× 22 143
Elena Crisà Italy 7 111 0.9× 21 0.3× 38 0.8× 142 3.5× 12 0.3× 28 201
Fryderyk Lorenz Sweden 10 79 0.6× 30 0.5× 3 0.1× 193 4.7× 6 0.2× 18 239
Ole Weiss Bjerrum Denmark 5 90 0.7× 30 0.5× 23 0.5× 159 3.9× 8 0.2× 5 190

Countries citing papers authored by Roman Hakl

Since Specialization
Citations

This map shows the geographic impact of Roman Hakl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Hakl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Hakl more than expected).

Fields of papers citing papers by Roman Hakl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Hakl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Hakl. The network helps show where Roman Hakl may publish in the future.

Co-authorship network of co-authors of Roman Hakl

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Hakl. A scholar is included among the top collaborators of Roman Hakl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Hakl. Roman Hakl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Staubach, Petra, Timothy Craig, Emel Aygören‐Pürsün, et al.. (2025). Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab. Allergy and Asthma Proceedings. 46(3). 200–208. 1 indexed citations
2.
Staubach, Petra, Raffi Tachdjian, Roman Hakl, et al.. (2024). Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks. Clinical & Experimental Allergy. 54(12). 1020–1023. 4 indexed citations
3.
Anderson, John, Emel Aygören‐Pürsün, Hugo Chapdelaine, et al.. (2024). LONG-TERM TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS WITH ORAL DEUCRICTIBANT: RAPIDE-2 EXTENSION STUDY RESULTS. Annals of Allergy Asthma & Immunology. 133(6). S35–S35.
4.
Souček, Přemysl, Kamila Réblová, Ondřej Zapletal, et al.. (2023). Myeloid lineage cells evince distinct steady-state level of certain gene groups in dependence on hereditary angioedema severity. Frontiers in Genetics. 14. 1123914–1123914. 1 indexed citations
5.
Vlková, Marcela, et al.. (2023). PLAUR splicing pattern in hereditary angioedema patients’ monocytes and macrophages. Molecular Biology Reports. 50(6). 4975–4982. 1 indexed citations
6.
Hakl, Roman & Jiří Litzman. (2023). Histamine intolerance. Vnitřní lékařství. 69(1). 37–40. 1 indexed citations
7.
Milota, Tomáš, Jitka Smetanová, Markéta Bloomfield, et al.. (2022). Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study. Frontiers in Immunology. 13. 835770–835770. 22 indexed citations
8.
Valerieva, Anna, Maria Staevska, Vesna Grivcheva‐Panovska, et al.. (2021). Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry. World Allergy Organization Journal. 14(4). 100535–100535. 7 indexed citations
9.
Zachová, Radana, Roman Hakl, Pavlína Králíčková, et al.. (2021). Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients. International Archives of Allergy and Immunology. 182(7). 642–649. 12 indexed citations
10.
Souček, Přemysl, Lucie Grodecká, Hana Grombiříková, et al.. (2020). Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation. Journal of Clinical Immunology. 40(3). 435–446. 18 indexed citations
11.
Valerieva, Anna, Maria Staevska, Miloš Jeseňák, et al.. (2019). Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 799–802. 22 indexed citations
12.
Vlková, Marcela, et al.. (2019). Neutrophils Are Dysregulated in Patients with Hereditary Angioedema Types I and II in a Symptom-Free Period. Mediators of Inflammation. 2019. 1–12. 8 indexed citations
13.
Valerieva, Anna, Maria Staevska, Miloš Jeseňák, et al.. (2019). Recombinant Human C1 Esterase Inhibitor as Short-Term Prophylaxis for Dental Procedures in Patients With Angioedema: A Case Series. Journal of Allergy and Clinical Immunology. 143(2). AB37–AB37. 1 indexed citations
14.
Moldovan, Dumitru, Jonathan A. Bernstein, Roman Hakl, & Anurag Relan. (2018). Safety of Recombinant Human C1 Esterase Inhibitor for Hereditary Angioedema Attacks in Pregnant Women. Journal of Allergy and Clinical Immunology. 141(2). AB53–AB53. 1 indexed citations
15.
Hakl, Roman, Irena Krčmová, Pavlína Králíčková, et al.. (2018). Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. Journal of Clinical Immunology. 38(7). 810–815. 20 indexed citations
16.
Bernstein, Jonine L., et al.. (2018). EXPERIENCE WITH RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR HEREDITARY ANGIOEDEMA ATTACKS DURING PREGNANCY. Annals of Allergy Asthma & Immunology. 121(5). S33–S33. 1 indexed citations
17.
Riedl, Marc A., Vesna Grivcheva‐Panovska, Dumitru Moldovan, et al.. (2017). Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. The Lancet. 390(10102). 1595–1602. 48 indexed citations
18.
Hakl, Roman, et al.. (2016). Hereditary angio-oedema with C1 inhibitor deficiency: Characteristics and diagnostic delay of Czech patients from one centre. Allergologia et Immunopathologia. 44(3). 241–245. 2 indexed citations
19.
Hakl, Roman. (2016). Současné možnosti léčby hereditárního angioedému. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fotis Psarros Breakdown of academic impact, for papers by Marianna De Muro Breakdown of academic impact, for papers by Cecelia Perkins Breakdown of academic impact, for papers by Elisabetta Colaci Breakdown of academic impact, for papers by Tülin Tuğlular Breakdown of academic impact, for papers by Juliana Schwaab Breakdown of academic impact, for papers by Giuseppe Auteri Breakdown of academic impact, for papers by Elena Crisà Breakdown of academic impact, for papers by Fryderyk Lorenz Breakdown of academic impact, for papers by Ole Weiss Bjerrum
Rankless by CCL
2026